ArticleClinical, cosmetic and investigational dermatology2025

Adverse Events Associated with Apremilast and Deucravacitinib for Psoriasis: A Pharmacovigilance Study Based on the FAERS Database.

Yuanyuan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.